<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">AiM</journal-id>
      <journal-title-group>
        <journal-title>Advances in Microbiology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2165-3402</issn>
      <publisher>
        <publisher-name>Scientific Research Publishing</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.4236/aim.2018.83012</article-id>
      <article-id pub-id-type="publisher-id">AiM-83183</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Articles</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Biomedical&amp;Life Sciences</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>


          Urinary Tract Infection among Pregnant Women at Pumwani Maternity Hospital, Nairobi, Kenya: Bacterial Etiologic Agents, Antimicrobial Susceptibility Profiles and Associated Risk Factors

        </article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Hellen</surname>
            <given-names>A. Onyango</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">
            <sup>*</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Carolyne</surname>
            <given-names>Ngugi</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>John</surname>
            <given-names>Maina</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>John</surname>
            <given-names>Kiiru</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff id="aff2">
        <addr-line>Department of Medical Microbiology, College of Health Sciences, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya</addr-line>
      </aff>
      <aff id="aff3">
        <addr-line>Centre of Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya</addr-line>
      </aff>
      <aff id="aff1">
        <addr-line>Department of Medical Microbiology, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya</addr-line>
      </aff>
      <author-notes>
        <corresp id="cor1">
          * E-mail:<email>honyango79@gmail.com(HAO)</email>;
        </corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>21</day>
        <month>03</month>
        <year>2018</year>
      </pub-date>
      <volume>08</volume>
      <issue>03</issue>
      <fpage>175</fpage>
      <lpage>187</lpage>
      <history>
        <date date-type="received">
          <day>10,</day>
          <month>January</month>
          <year>2018</year>
        </date>
        <date date-type="rev-recd">
          <day>18,</day>
          <month>March</month>
          <year>2018</year>
        </date>
        <date date-type="accepted">
          <day>21,</day>
          <month>March</month>
          <year>2018</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement>
        <copyright-year>2014</copyright-year>
        <license>
          <license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p>
        </license>
      </permissions>
      <abstract>
        <p>


          Urinary Tract Infections (UTIs) during pregnancy are among the most common infections worldwide and can lead to poor perinatal and maternal outcomes. This study determined the prevalence of UTIs during pregnancy, associated risk factors and antimicrobial susceptibility profiles of associated bacterial pathogens. A cross-sectional study was conducted among 210 pregnant women attending antenatal clinic at Pumwani Maternity hospital. Their social-demographic profiles were obtained using a structured questionnaire. Cultures were done from midstream urine and antimicrobial susceptibility testing determined using the disc diffusion test. The overall prevalence of UTI was 15.7% regardless of the women’s age, parity and stage of gestation. Prevalence of asymptomatic and symptomatic bacteriuria was 4.3% and 11.4% respectively. Material of undergarment and frequency of changing the undergarments were found to contribute significantly to the acquisition of UTI (P &lt; 0.05). E. coli was the most predominant UTI organism at (44.5%) followed by K. pneumoniae (21.2%) and S. aureus (15.1%). Almost a half (over 49%) of all Gram-negative organisms showed resistance prevalence against third generation cephalosporins, fluoroquinolones, Sulfamethoxazole-Trimethoprim, Cefoxitin, Nitrofurantoin and Amoxicillin-clavulanic acid. Gram-positive strains were susceptible to Amoxicillin-clavulanic acid, Nitrofurantoin, Linezolid and Ofloxacin. The prevalence of multi-drug resistance (MDR) in all study isolates was 96%. Our data suggest a serious resistance trend among UTI strains and more should be done to slow down this trend. Pregnant women should be screened by urine culture and treatment be guided by the antimicrobial susceptibility data.

        </p>
      </abstract>
      <kwd-group>
        <kwd>Urinary Tract Infection</kwd>
        <kwd> Pregnancy</kwd>
        <kwd> Risk Factors</kwd>
        <kwd> Antimicrobial Resistance</kwd>
        <kwd> ESBL</kwd>
        <kwd> MRSA</kwd>
        <kwd> MDR</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="s1">
      <title>1. Introduction</title>
      <p>
        In developing countries, UTIs are among the most common health problems affecting women in their reproductive ages. Pregnant women are more susceptible to UTIs due to a combination of hormonal and physiologic changes that predispose them to bacteriuria [<xref ref-type="bibr" rid="scirp.83183-ref1">1</xref>] . The incidence of acute pyelonephritis in pregnant women is also significantly increased [<xref ref-type="bibr" rid="scirp.83183-ref2">2</xref>] . Factors such as history of recurrent urinary tract infection, diabetes, low social economic status, increasing maternal age, multiparity, and anatomical abnormalities of the urinary tract have also been associated with a two fold increase in bacteriuria during pregnancy [<xref ref-type="bibr" rid="scirp.83183-ref2">2</xref>] , but the risk factors associated with UTIs in Africa remains poorly investigated.
      </p>
      <p>
        Globally, the prevalence of UTI in pregnancy ranges between 13% - 33% with symptomatic bacteriuria occurring in 1% - 18% while asymptomatic cases are noted in 2% - 10% of women [<xref ref-type="bibr" rid="scirp.83183-ref3">3</xref>] . The prevalence has remained constant and most of the recent observational studies, including those from developing countries, report almost similar rates [<xref ref-type="bibr" rid="scirp.83183-ref2">2</xref>] . The most common agent implicated in symptomatic and asymptomatic bacteriuria is Escherichia coli that is responsible for 70% - 80% of the infections [<xref ref-type="bibr" rid="scirp.83183-ref4">4</xref>] . Other microorganisms include Staphylococcus spp., Klebsiella pneumoniae, Proteus spp., Pseudomonas aeruginosa, Enterococcus spp. and Acinetobacter [<xref ref-type="bibr" rid="scirp.83183-ref5">5</xref>] . Past studies indicate that UTI among pregnant mothers in Kenya range from 10% - 19% [<xref ref-type="bibr" rid="scirp.83183-ref6">6</xref>] . However, most of these studies concentrate on selected bacterial pathogens and the larger spectrum of bacterial etiologic agents remains unknown. Furthermore, the socio-demographic and lifestyle factors associated with UTIs among pregnant women in Kenya remain uninvestigated.
      </p>
      <p>
        In many hospitals in developing countries such as Kenya, routine urine culture is not carried out even for antenatal mothers. Currently, most patients are treated empirically without culture and antimicrobial susceptibility testing (AST) and treatment is therefore based on empiric guidelines that are rarely updated [<xref ref-type="bibr" rid="scirp.83183-ref7">7</xref>] . Even where UTI tests are done, only dipstick analysis and direct wet microscopy of urine are used, but these tests have poor positive and negative predictive values to detect bacteriuria particularly in asymptomatic persons [<xref ref-type="bibr" rid="scirp.83183-ref8">8</xref>] . We hypothesize that the overreliance on these methods and absence of culture and susceptibility testing have partially led to under-diagnosis of UTIs and this may be fueling the rising cases of treatment failure. In standard urine culture, a colony count of 10<sup>5</sup> CFU/ml is usually considered significant for infection [<xref ref-type="bibr" rid="scirp.83183-ref8">8</xref>] , but there’s missing data regarding the phenotypic characteristics of isolates whose counts fall below this threshold. Currently, such counts are regarded as contaminants. It is therefore not known if such counts represent a receding infection or an infection that is establishing. In this study, we compared the results of antimicrobial resistance phenotypes from UTI cases and those normally regarded as contaminants.
      </p>
      <p>Results of this study provide critical data to care givers and health planners regarding diagnosis, common etiological agents and probable treatment options with regard to antimicrobial resistance. This study also identified associated risk factors for UTI amongst pregnant women attending antenatal clinic at Pumwani Maternity Hospital (The largest antenatal clinic in Kenya).</p>
    </sec>
    <sec id="s2">
      <title>2. Materials and Methods</title>
      <sec id="s2_1">
        <title>2.1. Study Site</title>
        <p>This was a cross sectional study carried out at Pumwani Maternity Hospital, an obstetric and referral hospital for expectant mothers in Nairobi, the Kenyan capital. The study targeted pregnant women seeking antenatal care services at the Hospital.</p>
      </sec>
      <sec id="s2_2">
        <title>2.2. Sampling Method</title>
        <p>Systematic random sampling technique was employed in recruiting participants until the expected study sample was attained. A structured questionnaire was used for gathering socio-demographic and lifestyle data from the participants. Participants were instructed on how to collect clean-catch midstream urine after signing the consent form. Each sample bottle had a date of collection and bar-code linked to the participant's questionnaire which was in turn linked to confidential patient information file.</p>
      </sec>
      <sec id="s2_3">
        <title>2.3. Urine Culture</title>
        <p>
          Urine aliquots of 10 &#181;l were plated directly on CLED, MacConkey and blood agar plates and incubated aerobically at 35˚C - 37˚C for 24 hours. Colony counts yielding bacterial growth of ≥100,000 (10<sup>5</sup>) CFU/ml or more of pure isolates were deemed significant UTI cases whereas those yielding lower values were deemed as contaminants. At least 3 colonies of similar morphology per patient were randomly selected from UTI plates and purified before biochemical identification. Gram stain was done for all colonies analyzed and biochemical tests carried out to identify the isolates to the species level [<xref ref-type="bibr" rid="scirp.83183-ref9">9</xref>] . In order to investigate the profiles of the presumed contaminants colonies from at least 15% plates yielding CFUs below the 10<sup>5</sup> CFU/ml thresholds were randomly selected and analyzed alongside those from UTI cases.
        </p>
      </sec>
      <sec id="s2_4">
        <title>2.4. Antimicrobial Susceptibility Testing</title>
        <p>
          Antimicrobial susceptibility testing of pure isolates was performed according to the Kirby-Bauer disc diffusion method [<xref ref-type="bibr" rid="scirp.83183-ref10">10</xref>] on Mueller Hinton agar (Oxoid, Ltd, England). The standard reference strains, S. aureus (ATCC-25923) and E. coli (ATCC-25922) were used as quality control organisms to ascertain antibiotic discs potency and quality of the test media. Results were interpreted based on CLSI 2016 guidelines [<xref ref-type="bibr" rid="scirp.83183-ref11">11</xref>] . The double disc synergy test was used to test for extended spectrum β-lactamase (ESBL) production following the CLSI (2015) guidelines. Isolates showing synergy zones between amoxicillin/clavulanic and one or more third generation cephalosporins were identified as ESBL-producers [<xref ref-type="bibr" rid="scirp.83183-ref12">12</xref>] Susceptibility to Cefoxitin was used for the detection of Methicillin Resistant Staphylococcus aureus-MRSA [<xref ref-type="bibr" rid="scirp.83183-ref13">13</xref>] .
        </p>
      </sec>
      <sec id="s2_5">
        <title>2.5. Data Analysis</title>
        <p>Data analysis was done using using the SAS software, version 9.3 (SAS Institute). Chi-square test was applied for P-value derivation for socio-demographic and risk factors associated with UTIs. Binary logistic regression analysis was carried out to generate the adjusted odds ratio with 95% confidence interval, an alpha of less than 0.05 (P &lt; 0.05) was considered statistically significant.</p>
      </sec>
    </sec>
    <sec id="s3">
      <title>3. Results</title>
    </sec>
    <sec id="s3_1">
      <title>3.1. Recruitment and Prevalence of UTI</title>
      <p>A total of 210 pregnant women were recruited in the study. The overall prevalence of UTI was 15.7%. Prevalence of asymptomatic and symptomatic bacteriuria was 4.3% and 11.4% respectively.</p>
    </sec>
    <sec id="s3_2">
      <title>3.2. Social-Demographic Characteristics</title>
      <p>
        Pregnant mothers in the age group of 21 - 30 years had the highest prevalence of UTI at 75.8% followed by those aged 31 - 40 years at 12.1%, below 20 years of age at 9.1% while those above the age of 40 years had the least prevalence of 3%. UTI prevalence was also high among mothers in the second trimester (60.6%) compared to third trimester (24.2%) and first trimester (15.2%). High prevalence of bacteriuria was observed among multiparous mothers (72.7%) as compared to nulliparous (27.3%). Despite these variations, there was no significant association between UTI and maternal age, parity, occupation, gestation, marital status or level of education P &gt; 0.05, <xref ref-type="table" rid="table1">Table 1</xref>.
      </p>
    </sec>
    <sec id="s3_3">
      <title>3.3. Lifestyle Factors</title>
      <p>
        Among the lifestyle factors surveyed, mothers with multiple partners were two times more likely to develop a UTI (OR 2.45; P &gt; 0.05) compared to those with a single partner <xref ref-type="table" rid="table2">Table 2</xref>. Those who used non-cotton undergarments were three times more likely to develop a UTI compared to those who used cotton undergarments (P = 0.001). This study also found that the frequency of changing undergarment was significantly associated with UTI, (P &lt; 0.05). Those who changed once were 2 times likely to develop UTI compared to those who changed twice. When respondents were asked to state what causes UTI, a larger proportion (37.6%) had no idea while others indicated that women got UTI from sexual intercourse (17.6%), poor urogenital hygiene (9%), contaminated toilets (25.7%) and damp panties (10%).
      </p>
    </sec>
    <sec id="s3_4">
      <title>3.4. Diversity of Bacterial Isolates from Urine</title>
      <p>From the 99 UTI isolates identified, 78 (78.8%) were gram negative while 21 (21.2%) were gram positive bacteria. E. coli was the most predominant UTI isolate at 44.5% followed by K. pneumoniae (21.2%) and S. aureus (15.1%). Other organisms included P. aeroginosa, Acinetobacter spp. and Enterococcus spp. each at 6.1%. Analysis of 15% of the urine samples that would have been classified as</p>
    </sec>
  </body>
          
            <back>
          <ref-list>
            <title>References</title>
            <ref id="scirp.83183-ref1">
              <label>1</label>
              <mixed-citation publication-type="other" xlink:type="simple">Aseel, M., Meer, F.A., Kuwari, M.A. and Ismail, M. (2011) Prevalence and Predictors of Asymptomatic Bacteriuria among Pregnant Women Attending Primary Health Care in Qatar. Qatar National Research Strategy, 2011, 1715.</mixed-citation>
            </ref>
            <ref id="scirp.83183-ref2">
              <label>2</label>
              <mixed-citation publication-type="other" xlink:type="simple">Schnarr, J. and Smaill, F. (2008) Asymptomatic Bacteriuria and Symptomatic Urinary Tract Infections in Pregnancy. European Journal of Clinical Investigation, 38, 50-57.</mixed-citation>
            </ref>
            <ref id="scirp.83183-ref3">
              <label>3</label>
              <mixed-citation publication-type="other" xlink:type="simple">Agersew, A., Feleke, M., Yitayai, S., Ketema, T., Afework, K. and Abebe, A. (2012) Bacteria Profile and Drug Susceptibility Pattern of Urinary Tract Infection in Pregnant Women at University of Gonden Teaching Hospital, Northwest Ethiopia. BMC Research Notes, 5, 197-204. &lt;br /&gt;https://doi.org/10.1186/1756-0500-5-197</mixed-citation>
            </ref>
            <ref id="scirp.83183-ref4">
              <label>4</label>
              <mixed-citation publication-type="other" xlink:type="simple">
                Masinde, A., Gumodoka, B., Kilonzo, A. and Mshana, S.E. (2009) Prevalence of urinary Tract Infection among Pregnant Women at Bugando Medical Centre, Mwanza, Tanzania. Tanzania Journal of Health Research, 11, 154-159.
                &lt;br /&gt;https://doi.org/10.4314/thrb.v11i3.47704
              </mixed-citation>
            </ref>
            <ref id="scirp.83183-ref5">
              <label>5</label>
              <mixed-citation publication-type="other" xlink:type="simple">Delzell Jr., J.E. and Lefevre, M.L. (2000) Urinary Tract Infections during Pregnancy. American Family Physician, 61, 713-721.</mixed-citation>
            </ref>
            <ref id="scirp.83183-ref6">
              <label>6</label>
              <mixed-citation publication-type="other" xlink:type="simple">Gilbert, N.M., O’brien, V.P., Hultgren, S., Macones, G., Lewis, W.G. and Lewis, A.L. (2013) Urinary Tract Infection as a Preventable Cause of Pregnancy Complications: Opportunities, Challenges, and a Global Call to Action. Global Advances in Health and Medicine, 2, 59-69. &lt;br /&gt;https://doi.org/10.7453/gahmj.2013.061</mixed-citation>
            </ref>
            <ref id="scirp.83183-ref7">
              <label>7</label>
              <mixed-citation publication-type="other" xlink:type="simple">Kose, Y., Abasiyanik, M.F. and Salih, B.A. (2007) Antibiotic Resistance Rates of Escherichia Coli Urinary Tract Isolates in Rize Province, Turkey. The Journal of Infection in Developing Countries, 1, 147-150.</mixed-citation>
            </ref>
            <ref id="scirp.83183-ref8">
              <label>8</label>
              <mixed-citation publication-type="other" xlink:type="simple">Nicolle, L.E., Bradley, S., Colgan, R., Rice, J.C., Schaeffer, A. and Hooton, T.M. (2005) Infectious Diseases Society of America Guidelines for the Diagnosis and Treatment of Asymptomatic Bacteriuria in Adults. Clinical Infectious Diseases, 40, 643-54. &lt;br /&gt;https://doi.org/10.1086/427507</mixed-citation>
            </ref>
            <ref id="scirp.83183-ref9">
              <label>9</label>
              <mixed-citation publication-type="other" xlink:type="simple">Monica, C. (2000) Biochemical Tests to Identify Bacteria. Cambridge University Press.</mixed-citation>
            </ref>
            <ref id="scirp.83183-ref10">
              <label>10</label>
              <mixed-citation publication-type="other" xlink:type="simple">Bauer, A.W., Kirby, W.M.M., Sherris, J.C. and Turck, M. (1996) Antibiotic Susceptibility Testing by a Standardized Single Disk Method. American Journal of Clinical Pathology, 45, 493-496.</mixed-citation>
            </ref>
            <ref id="scirp.83183-ref11">
              <label>11</label>
              <mixed-citation publication-type="other" xlink:type="simple">Clinical Laboratory Standard Institute (CLSI) (2016) Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Sixth Informational Supplement. Vol. CLSI Docum, No. Wayne, PA.</mixed-citation>
            </ref>
            <ref id="scirp.83183-ref12">
              <label>12</label>
              <mixed-citation publication-type="other" xlink:type="simple">
                Rawat, D. and Nair, D. (2010) Extended-Spectrum β-Lactamases in Gram Negative Bacteria. Journal of Global Infectious Diseases, 2, 263-274.
                &lt;br /&gt;https://doi.org/10.4103/0974-777X.68531
              </mixed-citation>
            </ref>
            <ref id="scirp.83183-ref13">
              <label>13</label>
              <mixed-citation publication-type="other" xlink:type="simple">Jain, A., Agarwal, A. and Verma, R.K. (2008) Cefoxitin Disc Diffusion Test for Detection of Meticillin-Resistant Staphylococci. Journal of Medical Microbiology, 57, 957-961. &lt;br /&gt;https://doi.org/10.1099/jmm.0.47152-0</mixed-citation>
            </ref>
            <ref id="scirp.83183-ref14">
              <label>14</label>
              <mixed-citation publication-type="other" xlink:type="simple">Andabati, G. and Byamugisha, J. (2010) Microbial Aetiology and Sensitivity of Asymptomatic Bacteriuria among Ante-Natal Mothers in Mulago Hospital, Uganda. African Health Sciences, 10, 349-352.</mixed-citation>
            </ref>
            <ref id="scirp.83183-ref15">
              <label>15</label>
              <mixed-citation publication-type="other" xlink:type="simple">Dimetry, S.R., El-tokhy, H.M., Abdo, N.M., Ebrahim, M.A. and Eissa, M. (2007) Urinary Tract Infection and Adverse Outcome of Pregnancy Clinical Pathology Department. The Journal of the Egyptian Public Health Association, 82, 203-218.</mixed-citation>
            </ref>
            <ref id="scirp.83183-ref16">
              <label>16</label>
              <mixed-citation publication-type="book" xlink:type="simple">Griebling, T.L. (2007) Urinary Tract Infection in Women. In: Litwin, M.S. and Saigal, C.S., Eds., Urologic Diseases in America, US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, US Government Printing Office: NIH Publication, Washington DC, 589-619.</mixed-citation>
            </ref>
            <ref id="scirp.83183-ref17">
              <label>17</label>
              <mixed-citation publication-type="other" xlink:type="simple">
                Hamdan, H.Z., Ziad, A.H.M., Ali, S.K. and Adam, I. (2011) Epidemiology of Urinary Tract Infections and Antibiotics Sensitivity among Pregnant Women at Khartoum North Hospital. Annals of Clinical Microbiology and Antimicrobials, 10, 2.
                &lt;br /&gt;https://doi.org/10.1186/1476-0711-10-2
              </mixed-citation>
            </ref>
            <ref id="scirp.83183-ref18">
              <label>18</label>
              <mixed-citation publication-type="other" xlink:type="simple">Guinto, V.T., De Guia, B., Festin, M.R. and Dowswell, T. (2010) Different Antibiotic Regimens for Treating Asymptomatic Bacteriuria in Pregnancy. The Cochrane Database of Systematic Reviews, No. 9, CD007855.</mixed-citation>
            </ref>
            <ref id="scirp.83183-ref19">
              <label>19</label>
              <mixed-citation publication-type="other" xlink:type="simple">Ayoyi, A.O., Kikuvi, G., Bii, C. and Kariuki, S. (2017) Prevalence, Aetiology and Antibiotic Sensitivity Profile of Asymptomatic Bacteriuria Isolates from Pregnant Women in Selected Antenatal Clinic from Nairobi, Kenya. Pan African Medical Journal, 26, 1-12. &lt;br /&gt;https://doi.org/10.11604/pamj.2017.26.41.10975</mixed-citation>
            </ref>
            <ref id="scirp.83183-ref20">
              <label>20</label>
              <mixed-citation publication-type="other" xlink:type="simple">Oladeinde, B.H., Omoregie, R. and Oladeinde, O.B. (2015) Asymptomatic Urinary Tract Infection among Pregnant Women Receiving Ante-Natal Care in a Traditional Birth Home in Benin City, Nigeria. Ethiopian Journal of Health Sciences, 15, 3-8.</mixed-citation>
            </ref>
            <ref id="scirp.83183-ref21">
              <label>21</label>
              <mixed-citation publication-type="other" xlink:type="simple">Kariuki, S., et al. (2007) Escherichia Coli from Community-Acquired Urinary Tract Infections Resistant to Fluoroquinolones and Extended-Spectrum Beta-Lactams. The Journal of Infection in Developing Countries, 1, 257-262.</mixed-citation>
            </ref>
          </ref-list>
        </back>
</article>